BioRestorative Therapies, Inc. (OTCMKTS:BRTXQ – Get Free Report)’s stock price hit a new 52-week high during mid-day trading on Tuesday . The company traded as high as $1.65 and last traded at $1.65, with a volume of 2740 shares traded. The stock had previously closed at $1.67.
BioRestorative Therapies Trading Down 1.0 %
The firm has a market capitalization of $2.71 billion, a price-to-earnings ratio of -1.56 and a beta of 102.36. The company has a fifty day moving average price of $1.59 and a two-hundred day moving average price of $1.54.
About BioRestorative Therapies
BioRestorative Therapies, Inc develops therapeutic products using cell and tissue protocols primarily involving adult stem cells. The company’s two core programs are related to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program includes a lead cell therapy candidate, BRTX-100 is a product formulated from autologous (or a person's own) cultured mesenchymal stem cells collected from the patient's bone marrow and intended for the non-surgical treatment of painful lumbosacral disc disorders.
Further Reading
- Five stocks we like better than BioRestorative Therapies
- 3 REITs to Buy and Hold for the Long Term
- NVIDIA’s AI Dominance: Why Analysts Predict Major Upside Ahead
- Options Trading – Understanding Strike Price
- These Stocks Are Using Buybacks to Unlock Big Gains for Investors
- How to Invest in Insurance Companies: A Guide
- This Is the Entry Into PepsiCo You’ve Been Waiting For
Receive News & Ratings for BioRestorative Therapies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioRestorative Therapies and related companies with MarketBeat.com's FREE daily email newsletter.
